Barclays logo
Barclays

May 15, 2026

Americas Small Cap Research Summary

Market ReportEquitiesHealth CareConsumer Discretionary

This Barclays Equity Research report provides a summary of rating and estimate changes for several Americas small-cap companies across healthcare, retail, financials, and technology sectors as of May 15, 2026.

Key Takeaways

  • 1.Addus Homecare (ADUS) faces significant operational headwinds due to a CMS Medicare home health and hospice moratorium, halting incremental supply and near-term M&A.
  • 2.Canada Goose (GOOS) reported strong sales growth (+18%) but carries risks to its FY27 guidance due to mix shifts impacting gross margins and broader macro challenges.
  • 3.Anteris Technologies (AVR) remains on track for its PARADIGM pivotal trial enrollment by 1Q27, with management amping up focus on clinical execution.

Table of Contents

  • Summary of Changes
  • Publications Summary
  • Financial Services
  • Healthcare
  • Industrials
  • Retail
  • Technology
  • Analyst(s) Certification(s)
  • Important Disclosures
  • Availability of Disclosures
  • Risk Disclosure(s)
  • Guide to the Barclays Fundamental Equity Research Rating System
  • Guide to the Barclays Research Price Target
  • Disclaimer

Document Preview

Page 1 of 5
Page 1 of Americas Small Cap Research Summary
Subscribe for full access

Access the Full Report

Get unlimited access to institutional research reports with a 14-day free trial.

Authors

Alex Scott, CFAAndrew Mok, CFAAdrienne Yih

Securities

ADUSGOOSAVR

Themes

Small-Cap VolatilityRegulatory HeadwindsClinical Trial Execution

Regions

North AmericaUnited StatesCanada